Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

RNTXRNTX
Showing 8 of 9 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in REIN THERAPEUTICS INC

NORTHERN TRUST CORP holds 159,720 shares of RNTX (REIN THERAPEUTICS INC), worth $166,109 as of 2026-Q2. The position was increased (+149.0% shares).

Current Value

$166,109

Current Shares

159,720

Total Value Change

+$74,908

Total Shares Change

+133,957

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
159,720
+149.0%
$166,1090.0%$1.04
25
2026-Q1
Increased
64,136
+58.5%
$83,3770.0%$1.15
21
2025-Q4
Increased
40,469
+57.1%
$46,9440.0%$1.07
20
2025-Q3
Unchanged
25,763
0.0%
$29,4990.0%$1.15
0
2025-Q2
Unchanged
25,763
0.0%
$36,0680.0%$1.47
0
2025-Q1
Unchanged
25,763
0.0%
$45,6010.0%$1.70
0
2024-Q4
Unchanged
25,763
0.0%
$59,2550.0%$2.32
0
2024-Q3
Unchanged
25,763
0.0%
$91,2010.0%$3.65
0

Other major holders of RNTX: VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used